Mobile Menu

Search Results

Search results for: Methods

An impact study on the rare disease community: a call to action

Jo Balfour, one of the founding members and current Operations Manager at Cambridge Rare Disease Network (CRDN), has collaborated with […]

Genetics Unzipped podcast: Sickness and susceptibility – the ancient war between genes and disease

Geneticist Dr Kat Arney takes a look at the ancient war between our genes and the pathogens that infect us, […]

Biologically-validated AI is how scientists are realising the full potential of single-cell RNA sequencing

The promise of single-cell gene expression data Genomic data are an excellent source of novel disease biomarkers and targets. In […]

A major cause of rare mitochondrial disease found

A study from the Murdoch Children’s Research Institute (MCRI) has found a genetic cause for a rare disease that causes […]

Studies find CRISPR gene-editing of human embryos give rise to unwanted results.

CRISPR gene-editing is a technique that allows the genomes of living organisms to be modified. Naturally, this has been looked […]

Capture the dark genome: From repeat-expansions to CRISPR unintended mutations – Webinar Summary

Tackling Disease-Related Repeat Expansion Analysis – Marzia Rossato What is the Dark Genome? The dark genome refers to parts of […]

Webinar: Capture the dark genome – From repeat-expansions to CRISPR unintended mutations

Sequenced genomes retain a surprisingly large number of “dark” regions – sections that have proven difficult to characterise via short-read […]

Deep learning in genomics – are we there yet?

As genomic sequencing becomes more routine, handling the sheer volume of data being produced is causing major issues. We must […]

100kb into the genome – a quest to improve target enrichment

*** This post was written by Dr. Anja Brunner, science writer (Science Inbound) Armed with a decade of experience in […]

Günther Brueggenwerth and Arndt Schmitz from Bayer tell us about Radiomics

We caught up with Günther Brueggenwerth and Arndt Schmitz from Bayer at the Festival of Genomics in January to talk […]